ARMO BioSciences, Inc. Contracts & Agreements
19 Contracts & Agreements
- Business Finance (5 contracts)
- Business Operations (1)
- Human Resources (2)
- Intellectual Property (3)
- Mergers & Acquisitions (1)
- Real Estate (2)
- Uncategorized (5)
- Agreement and Plan of Merger by and between Eli Lilly and Company, Bluegill Acquisition Corporation and ARMO BioSciences, Inc., dated May 9, 2018 (Filed With SEC on May 10, 2018)
- Tender and Support Agreement, dated as of May 9, 2018, by and among Eli Lilly and Company, Bluegill Acquisition Corporation and certain stockholders of ARMO BioSciences, Inc (Filed With SEC on May 10, 2018)
- Form of Executive Employment Agreement between ARMO BioSciences, Inc. and each of its executive officers (Filed With SEC on March 30, 2018)
- Form of Underwriting Agreement (Filed With SEC on January 16, 2018)
- Form of Registrants Common Stock Certificate (Filed With SEC on January 16, 2018)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on January 16, 2018)
- ARMO BioSciences, Inc. 2018 Equity Incentive Plan, including form agreements, to be in effect upon completion of the offering (Filed With SEC on January 16, 2018)
- ARMO BioSciences, Inc. 2018 Employee Stock Purchase Plan to be in effect upon completion of the offering (Filed With SEC on January 16, 2018)
- Amended and Restated Investors Rights Agreement, dated August 11, 2017, between the Registrant and the parties thereto (Filed With SEC on December 29, 2017)
- ARMO BioSciences, Inc. 2012 Stock Plan and forms of agreements thereunder (Filed With SEC on December 29, 2017)
- Offer Letter, dated December 31, 2012, between the Registrant and Peter Van Vlasselaer, Ph.D (Filed With SEC on December 29, 2017)
- Offer Letter, dated March 19, 2016, between the Registrant and Gail Brown, M.D (Filed With SEC on December 29, 2017)
- Offer Letter, dated September 5, 2017, between the Registrant and Joseph Leveque, M.D (Filed With SEC on December 29, 2017)
- Offer Letter, dated October 26, 2017, between the Registrant and Herb Cross (Filed With SEC on December 29, 2017)
- Lease, dated February 19, 2013, between the Registrant and Metropolitan Life Insurance Company (Filed With SEC on December 29, 2017)
- First Amendment to Lease between the Registrant and Metropolitan Life Insurance Company, dated October 14, 2016 (Filed With SEC on December 29, 2017)
- Exclusive Patent License Agreement, dated December 12, 2012, between Merck, Sharp & Dohme Corporation and the Registrant (Filed With SEC on December 29, 2017)
- Amendment No. 1 to the Exclusive Patent License between Merck, Sharp & Dohme Corporation and the Registrant, dated December 12, 2012 (Filed With SEC on December 29, 2017)
- Amendment No. 2 to the Exclusive Patent License between Merck, Sharpe & Dohm Corporation and the Registrant, dated July 11, 2017 (Filed With SEC on December 29, 2017)
